{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:40:51Z","timestamp":1790700051226,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.dsx.2022.102693","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T02:16:42Z","timestamp":1670897802000},"page":"102693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effectiveness of the pomegranate extract in improving hepatokines and serum biomarkers of non-alcoholic fatty liver disease: A randomized double blind clinical trial"],"prefix":"10.1016","volume":"17","author":[{"given":"Sima","family":"Jafarirad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Mohammadtaghvaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Dastoorpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Alavinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dsx.2022.102693_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12937-020-00580-6","article-title":"Association of the dietary patterns with the risk of non-alcoholic fatty liver disease among Iranian population: a case-control study","volume":"19","author":"Dehghanseresht","year":"2020","journal-title":"Nutr J"},{"issue":"6","key":"10.1016\/j.dsx.2022.102693_bib2","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.dsx.2020.09.026","article-title":"Pathophysiological mechanisms underlying MAFLD","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metabol Syndr"},{"issue":"5","key":"10.1016\/j.dsx.2022.102693_bib3","first-page":"329","article-title":"Physiopathology of nonalcoholic fatty liver disease: from diet to nutrigenomics","volume":"25","author":"Meneghel","year":"2022","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"10.1016\/j.dsx.2022.102693_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cld.2007.02.011","article-title":"Pathogenesis of non-alcoholic steatohepatitis: human data","volume":"11","author":"Edmison","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"10","key":"10.1016\/j.dsx.2022.102693_bib5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","article-title":"Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Madan","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.dsx.2022.102693_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/bj20030676","article-title":"Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A","volume":"376","author":"Denecke","year":"2003","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.dsx.2022.102693_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001765","article-title":"Fetuin-A induces cytokine expression and suppresses adiponectin production","volume":"3","author":"Hennige","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.dsx.2022.102693_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.dsx.2022.102693_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133496","article-title":"Fish oil supplements lower serum lipids and glucose in correlation with a reduction in plasma fibroblast growth factor 21 and prostaglandin E2 in nonalcoholic fatty liver disease associated with hyperlipidemia: a randomized clinical trial","volume":"10","author":"Qin","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.dsx.2022.102693_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J\u00a0Intern Med"},{"issue":"9","key":"10.1016\/j.dsx.2022.102693_bib11","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.4254\/wjh.v14.i9.1718","article-title":"Therapies for non-alcoholic fatty liver disease: a 2022 update","volume":"14","author":"Shen","year":"2022","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.dsx.2022.102693_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","article-title":"Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1, and NF-kappa B pathways","volume":"53","author":"Xiao","year":"2014","journal-title":"Eur J Nutr"},{"issue":"6","key":"10.1016\/j.dsx.2022.102693_bib13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1080\/10408398.2020.1749825","article-title":"Pomegranate as a source of bioactive constituents: a review on their characterization, properties and applications","volume":"61","author":"Pirzadeh","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.dsx.2022.102693_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ctcp.2015.12.003","article-title":"Effects of pomegranate extract supplementation on inflammation in overweight and obese individuals: a randomized controlled clinical trial","volume":"22","author":"Hosseini","year":"2016","journal-title":"Compl Ther Clin Pract"},{"issue":"1","key":"10.1016\/j.dsx.2022.102693_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ejcn.2016.151","article-title":"Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients","volume":"71","author":"Ghavipour","year":"2017","journal-title":"Eur J Clin Nutr"},{"issue":"11","key":"10.1016\/j.dsx.2022.102693_bib16","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1089\/ars.2013.5538","article-title":"Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin","volume":"21","author":"Zou","year":"2014","journal-title":"Antioxidants Redox Signal"},{"issue":"8","key":"10.1016\/j.dsx.2022.102693_bib17","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/jsfa.8042","article-title":"Agriculture. Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation","volume":"97","author":"Noori","year":"2017","journal-title":"J\u00a0Sci Food Agric"},{"issue":"1","key":"10.1016\/j.dsx.2022.102693_bib18","first-page":"59","article-title":"Effects of pomegranate juice on liver enzymes (ALT, ALP, AST) in diabetic and non-diabetic rats","volume":"7","author":"Hosseini","year":"2014","journal-title":"J\u00a0Anim Physiol Anim Nutr"},{"issue":"11","key":"10.1016\/j.dsx.2022.102693_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201800160","article-title":"The endotoxemia marker lipopolysaccharide-binding protein is reduced in overweight-obese subjects consuming pomegranate extract by modulating the gut microbiota: a randomized clinical trial","volume":"62","author":"Gonz\u00e1lez-Sarr\u00edas","year":"2018","journal-title":"Mol Nutr Food Res"},{"issue":"5\u20136","key":"10.1016\/j.dsx.2022.102693_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1024\/0300-9831\/a000292","article-title":"Effects of pomegranate and orange juice on antioxidant status in non-alcoholic fatty liver disease patients: a randomized clinical trial","volume":"85","author":"Ekhlasi","year":"2015","journal-title":"Int J Vitam Nutr Res"},{"issue":"1","key":"10.1016\/j.dsx.2022.102693_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/JMAU.JMAU_5_18","article-title":"Histological, immunohistochemical, and biochemical study of experimentally induced fatty liver in adult male albino rat and the possible protective role of pomegranate","volume":"6","author":"Hassan","year":"2018","journal-title":"J\u00a0Microsc Ultrastruct"},{"issue":"10","key":"10.1016\/j.dsx.2022.102693_bib22","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1381\/096089206778663805","article-title":"Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement","volume":"16","author":"Dixon","year":"2006","journal-title":"Obes Surg"},{"issue":"6","key":"10.1016\/j.dsx.2022.102693_bib23","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/hep.20251","article-title":"Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss","volume":"39","author":"Dixon","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dsx.2022.102693_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00592-013-0516-4","article-title":"Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding","volume":"51","author":"Folini","year":"2014","journal-title":"Acta Diabetol"},{"issue":"3","key":"10.1016\/j.dsx.2022.102693_bib25","first-page":"667","article-title":"Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver","volume":"13","author":"Al-Jiffri","year":"2013","journal-title":"Afr Health Sci"},{"issue":"10","key":"10.1016\/j.dsx.2022.102693_bib26","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1002\/ptr.7249","article-title":"The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: a randomized double-blind clinical trial","volume":"35","author":"Goodarzi","year":"2021","journal-title":"Phytother Res"},{"issue":"24","key":"10.1016\/j.dsx.2022.102693_bib27","doi-asserted-by":"crossref","first-page":"10050","DOI":"10.1021\/jf071689v","article-title":"Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size","volume":"55","author":"Heber","year":"2007","journal-title":"J\u00a0Agric Food Chem"},{"issue":"4","key":"10.1016\/j.dsx.2022.102693_bib28","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/jvim.14716","article-title":"Sensitivity and specificity of plasma ALT, ALP, and bile acids for hepatitis in Labrador Retrievers","volume":"31","author":"Dirksen","year":"2017","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.dsx.2022.102693_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2016.02.017","article-title":"Effects of endurance and endurance\u2013strength exercise on biochemical parameters of liver function in women with abdominal obesity","volume":"80","author":"Skrypnik","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.dsx.2022.102693_bib30","first-page":"1076","article-title":"Acute hyperenergetic, high-fat feeding increases circulating FGF21, LECT2, and fetuin-A in healthy men","volume":"150","author":"Willis","year":"2020","journal-title":"J\u00a0Nutr"},{"issue":"12","key":"10.1016\/j.dsx.2022.102693_bib31","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1210\/jc.2012-2414","article-title":"Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose","volume":"97","author":"Ou","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.dsx.2022.102693_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015534","article-title":"Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile","volume":"5","author":"Lin","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.dsx.2022.102693_bib33","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1210\/jc.2008-1505","article-title":"Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss","volume":"93","author":"Reinehr","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.dsx.2022.102693_bib34","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1210\/jc.2010-0148","article-title":"Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss","volume":"95","author":"Brix","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.dsx.2022.102693_bib35","article-title":"Interaction between plasma fetuin-A and free fatty acids predicts changes in insulin sensitivity in response to long-term exercise","volume":"5","author":"Lee","year":"2017","journal-title":"Phys Rep"},{"issue":"3","key":"10.1016\/j.dsx.2022.102693_bib36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/cen.12076","article-title":"The effects of caloric restriction on F etuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial","volume":"79","author":"Choi","year":"2013","journal-title":"Clin Endocrinol"},{"issue":"19","key":"10.1016\/j.dsx.2022.102693_bib37","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.3390\/ijms20194692","article-title":"Fibroblast growth factor 21 and the adaptive response to nutritional challenges","volume":"20","author":"Mart\u00ednez-Garza","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.dsx.2022.102693_bib38","first-page":"1","article-title":"The role of hepatokines in cardiovascular disease","volume":"5","author":"Roever","year":"2015","journal-title":"Metabolic Synd"},{"key":"10.1016\/j.dsx.2022.102693_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fendo.2015.00147","article-title":"Research perspectives on the regulation and physiological functions of FGF21 and its association with NAFLD","volume":"6","author":"Inagaki","year":"2015","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.dsx.2022.102693_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.dsx.2022.102693_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1039\/C2FO30034F","article-title":"function. Pomegranate: a fruit that ameliorates metabolic syndrome","volume":"4","author":"Medjakovic","year":"2013","journal-title":"Food Funct"},{"key":"10.1016\/j.dsx.2022.102693_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jnutbio.2016.02.003","article-title":"Pomegranate extract and exercise provide additive benefits on improvement of immune function by inhibiting inflammation and oxidative stress in high-fat-diet-induced obesity in rats","volume":"32","author":"Zhao","year":"2016","journal-title":"J\u00a0Nutr Biochem"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402122003101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402122003101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:21:21Z","timestamp":1761729681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402122003101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1871402122003101"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2022.102693","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of the pomegranate extract in improving hepatokines and serum biomarkers of non-alcoholic fatty liver disease: A randomized double blind clinical trial","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2022.102693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102693"}}